ProjectCRB1 Therapeutics – Korrektur einer häufigen CRB1 Mutation mittels RNA-Baseneditierung - Entwicklung einer…
Basic data
Acronym:
CRB1 Therapeutics
Title:
Korrektur einer häufigen CRB1 Mutation mittels RNA-Baseneditierung - Entwicklung einer neuartigen Therapie der retinalen Degeneration
Duration:
01/07/2022 to 30/06/2025
Abstract / short description:
The project aims for the development of on oligonucleotide drug that applies a novel RNA editing mechanism to treat LCA/RP-patients harboring the common CRB1 mutation.
Keywords:
RNA
ribonucleic acid, Ribonukleinsäure
medicine
Medizin
Retina
retina, Netzhaut
genetic engineering
Gentechnik
drugs
Arzneimittel
Involved staff
Managers
Faculty of Science
University of Tübingen
University of Tübingen
Interfaculty Institute of Biochemistry (IFIB)
Interfaculty Institutes
Interfaculty Institutes
Contact persons
Faculty of Medicine
University of Tübingen
University of Tübingen
Local organizational units
Interfaculty Institute of Biochemistry (IFIB)
Interfaculty Institutes
University of Tübingen
University of Tübingen
Faculty of Medicine
University of Tübingen
Faculty of Science
University of Tübingen
Funders
Bonn, Nordrhein-Westfalen, Germany